Muhammad Hammadah, MD
Basic profileThe University of Texas at San Antonio Health Science Center
Muhammad Hammadah is a Cardiology physician affiliated with The University of Texas at San Antonio Health Science Center. OpenAlex indexes 198 publications with 4,471 citations (h-index 40).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4502 Medical Dr
San Antonio, TX 782294402
Telephone
210-358-0330Provider last certified this registry record 11 May 2026.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Edwards Lifesciences CorporationProgram year202514 payments
- Teleflex LLCProgram year20254 payments
- CARDIVA MEDICAL, INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.2%Beta blocker23.4%Metoprolol Succinate58%Carvedilol34%Metoprolol Tartrate8%Part D<11 patientsStatin12.8%Atorvastatin Calcium62%Rosuvastatin Calcium24%Pravastatin Sodium14%Part D<11 patients+ 10 more classes in this area
Blood & clotting
15.6%Factor Xa inhibitor7.9%Eliquis86%Xarelto14%Part D<11 patientsP2Y12 inhibitor7.7%Clopidogrel76%Brilinta24%Part D<11 patientsMetabolism & gastrointestinal
6.2%SGLT2 inhibitor5.1%Farxiga75%Jardiance25%Part D<11 patientsProton pump inhibitor1%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Racial Disparities in Adverse Cardiovascular Outcomes After a Myocardial Infarction in Young or Middle‐Aged Patients
Journal of the American Heart Association
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Marcos Restrepo, MD, MSc
The University of Texas at San Antonio Health Science Center
Robert Brzyski, MD
The University of Texas at San Antonio Health Science Center
Devjit Tripathy, MD
The University of Texas at San Antonio Health Science Center
Robert Svatek, MD
The University of Texas at San Antonio Health Science Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”